There is a clear surge in noteworthy institutional activity around shares in MetLife Inc. (MET), as numerous establishments have been increasing or initiating a position. Key examples include Commerzbank, Monument Capital Management, and Leo Wealth. Other entities, such as Mirae Asset and 111 Capital, also boosted their MET holdings. Notably, key firms like Wells Fargo, Barclays, and Morgan Stanley have maintained high ratings, with the latter raising MET's price target to $96-$97.
Despite the market challenges, MetLife has not wavered in its steady dividend yield, announcing a $0.57 quarterly dividend. Variations in stake levels were seen from entities such as Robeco Institutional Asset Management, Cullinan Associates, and Iowa State Bank.
However, financial performance stabiity remains a question, as Q2 earnings reportedly missed revenue estimates, and while some analysts predict price upliftment, others argue that MetLife's stock is underperforming in comparison to the Dow.
On the corporate responsibility front, MET is aligning with Global Citizen to drive social impact, showing the company's increasing attention to sustainability initiatives.
Metlife MET News Analytics from Fri, 07 Mar 2025 08:00:00 GMT to Sat, 11 Oct 2025 10:50:12 GMT - Rating 7 - Innovation 4 - Information 5 - Rumor 3
